The latest content updates from the pharmaceutical-technology.com web site http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ http://www.pharmaceutical-technology.com/content/images/logo_big.gif http://www.pharmaceutical-technology.com/news/newsstatins-may-increase-risk-diabetes-risk-study http://www.pharmaceutical-technology.com/news/newsstatins-may-increase-risk-diabetes-risk-study Some cholesterol-lowering drugs may put patients at an increased risk of developing type-2 diabetes, according to a new study. Thu, 23 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsscientists-step-closer-to-developing-universal-influenza-jab http://www.pharmaceutical-technology.com/news/newsscientists-step-closer-to-developing-universal-influenza-jab Scientists in the US have edged a step closer to developing a universal vaccine that would protect against multiple strains of influenza without the need for an annual seasonal flu jab. Thu, 23 May 2013 09:00:00 GMT http://www.pharmaceutical-technology.com/news/newsboehringer-responds-to-fda-warning-letter http://www.pharmaceutical-technology.com/news/newsboehringer-responds-to-fda-warning-letter Boehringer-Ingelheim has responded to a warning letter issued by the US Food and Drug Administration that faults the company for not correcting “significant violations” of good manufacturing practice at its facility in Rhein, Germany. Wed, 22 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsactavis-to-acquire-warner-chilcott-in-85-billion-deal http://www.pharmaceutical-technology.com/news/newsactavis-to-acquire-warner-chilcott-in-85-billion-deal US drug maker Actavis has struck a $5bn deal to acquire Ireland’s Warner Chilcott as it looks to fend off takeover threats. Wed, 22 May 2013 09:00:00 GMT http://www.pharmaceutical-technology.com/news/newsalzheimers-drug-trial-coincides-with-uks-dementia-awareness-week http://www.pharmaceutical-technology.com/news/newsalzheimers-drug-trial-coincides-with-uks-dementia-awareness-week TauRx Therapeutics has announced that the first of over 100 UK patients have enrolled in the global Phase III clinical trials of its experimental Alzheimer’s drug LMTX. Tue, 21 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsranbaxy-laboratories-gets-tentative-approval-for-hiv-combination-therapy http://www.pharmaceutical-technology.com/news/newsranbaxy-laboratories-gets-tentative-approval-for-hiv-combination-therapy The US Food and Drug Administration has granted tentative approval for a fixed dose formulation of two generic drugs for use in combination with antiretrovirals. Mon, 20 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsuk-scientists-hail-brain-disease-breakthrough http://www.pharmaceutical-technology.com/news/newsuk-scientists-hail-brain-disease-breakthrough Scientists in the UK have mapped a pathway that generates “aberrant” forms of proteins at the root of degenerative diseases such as Alzheimer’s and Parkinson’s. Mon, 20 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsbayer-acquires-herbal-medicines-manufacturer http://www.pharmaceutical-technology.com/news/newsbayer-acquires-herbal-medicines-manufacturer Bayer Pharmaceuticals has struck a deal to acquire Germany’s Steigerwald Arzneimittelwerk, a privately held company specialising in herbal medicines. Sun, 19 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newselan-strikes-two-more-drug-deals-to-fend-off-royalty-pharma-bid http://www.pharmaceutical-technology.com/news/newselan-strikes-two-more-drug-deals-to-fend-off-royalty-pharma-bid Irish pharmaceutical company Elan has agreed to buy two private drug companies and plans to buy back more shares as it looks to fend off a takeover bid from US investment firm Royalty Pharma. Sun, 19 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/contractors/lab_equip/priorclave-autoclaves/presspriorclave-celebrates-25-years-in-business.html http://www.pharmaceutical-technology.com/contractors/lab_equip/priorclave-autoclaves/presspriorclave-celebrates-25-years-in-business.html Top-loading laboratory autoclaves are the longest serving stalwarts of the Priorclave steam steriliser range, a 100l model being the first produced and to leave the company's factory in 1988 when it started trading, and through dedicated service and … Fri, 17 May 2013 11:26:00 GMT http://www.pharmaceutical-technology.com/contractors/oligos/bachem-ag/pressnew-peptides-biochemicals-amino-acid-derivatives-and-immunology-products-added-to-bachems-online-catalogue.html http://www.pharmaceutical-technology.com/contractors/oligos/bachem-ag/pressnew-peptides-biochemicals-amino-acid-derivatives-and-immunology-products-added-to-bachems-online-catalogue.html Bachem is continuously expanding and updating its extensive range of biologically active peptides, amino acid derivatives, biochemicals and immunology products. Fri, 17 May 2013 11:03:00 GMT http://www.pharmaceutical-technology.com/contractors/machines-labelling/bonfiglioli/pressbonfiglioli-to-attend-envasealimentek-2013-in-buenos-aires-argentina.html http://www.pharmaceutical-technology.com/contractors/machines-labelling/bonfiglioli/pressbonfiglioli-to-attend-envasealimentek-2013-in-buenos-aires-argentina.html Envase/Alimentek 2013 is the meeting place for the leading manufacturers and distributors of raw materials, equipment and machinery for bottling, packaging and packing of foods and drinks, allowing them to promote their latest products and services. Fri, 17 May 2013 10:44:00 GMT http://www.pharmaceutical-technology.com/contractors/machines-labelling/bonfiglioli/pressbonfiglioli-to-exhibit-at-pack-expo-las-vegas-us.html http://www.pharmaceutical-technology.com/contractors/machines-labelling/bonfiglioli/pressbonfiglioli-to-exhibit-at-pack-expo-las-vegas-us.html Pack Expo Las Vegas 2013 will be the year's most comprehensive showcase of packaging, processing and integrated solutions. Explosive growth - with an unprecedented number of innovations - has marked every successive show. Fri, 17 May 2013 10:43:00 GMT http://www.pharmaceutical-technology.com/news/newsuk-firm-halts-sale-of-convulsion-drug-to-arkansas-over-death-row-use http://www.pharmaceutical-technology.com/news/newsuk-firm-halts-sale-of-convulsion-drug-to-arkansas-over-death-row-use UK-based pharmaceutical company Hikma has stopped supplying convulsion drug phenobarbital to Arkansas in the US to prevent it being used in state executions. Thu, 16 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsfda-approves-radiation-prostate-cancer-drug http://www.pharmaceutical-technology.com/news/newsfda-approves-radiation-prostate-cancer-drug The US Food and Drug Administration has approved a new drug for the treatment of an advanced type of prostate cancer that spreads to the bones. Thu, 16 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/contractors/events/temperature-maintenance-of-biopharmaceuticals-2013/ http://www.pharmaceutical-technology.com/contractors/events/temperature-maintenance-of-biopharmaceuticals-2013/ Continuing on from the success of our 2012 launch year, the Temperature Maintenance of Biopharmaceuticals returns on 5-6 June in Boston, MA, bringing a renewed focus on delivering the most up-to-date... Thu, 16 May 2013 16:25:00 GMT http://www.pharmaceutical-technology.com/contractors/machines-labelling/inova/ http://www.pharmaceutical-technology.com/contractors/machines-labelling/inova/ Optima Pharma consists of three top-quality brands: Inova (sterile filling), Klee (freeze dyring) and Kugler (nonsterile filling). Thanks to years of specializing, Optima Pharma offers a comprehensive, cutting-edge range of products. Wed, 15 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsroche-releases-positive-results-for-first-of-its-kind-leukaemia-drug http://www.pharmaceutical-technology.com/news/newsroche-releases-positive-results-for-first-of-its-kind-leukaemia-drug A Phase III study into the effectiveness of a first-of-its-kind targeted cancer antibody drug developed by Roche for patients with chronic lymphocytic leukaemia (CLL) and co-existing medical conditions has yielded positive results. Wed, 15 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/news/newsus-human-cloning-breakthrough-turns-skin-cells-into-embryos http://www.pharmaceutical-technology.com/news/newsus-human-cloning-breakthrough-turns-skin-cells-into-embryos For the first time ever, scientists in the US have turned human skin cells into early-stage embryos, which were then used to create specialised tissue cells for transplant operations. Wed, 15 May 2013 23:00:00 GMT http://www.pharmaceutical-technology.com/contractors/consult/global-vision/pressglobal-vision-selected-by-pfizer-for-worldwide-deployment-of-automated-proofreading-solutions.html http://www.pharmaceutical-technology.com/contractors/consult/global-vision/pressglobal-vision-selected-by-pfizer-for-worldwide-deployment-of-automated-proofreading-solutions.html Global Vision, the industry leader in the development of automated proofreading solutions, today announced that it has been selected by Pfizer for worldwide deployment as its proofreading technology solution provider. Wed, 15 May 2013 15:36:00 GMT